CN Stock MarketDetailed Quotes

002788 Luyan Pharma

Watchlist
  • 7.77
  • +0.06+0.78%
Trading Jul 4 09:31 CST
3.02BMarket Cap8.21P/E (TTM)

Luyan Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
6.08%5.14B
1.97%19.85B
3.15%14.78B
7.32%10.02B
4.40%4.84B
10.93%19.46B
10.16%14.32B
10.22%9.34B
11.32%4.64B
12.94%17.55B
Operating revenue
6.08%5.14B
1.97%19.85B
3.15%14.78B
7.32%10.02B
4.40%4.84B
10.93%19.46B
10.16%14.32B
10.22%9.34B
11.32%4.64B
12.94%17.55B
Other operating revenue
----
7.03%60.56M
----
3.13%26.54M
----
52.24%56.58M
----
89.66%25.73M
----
3.15%37.16M
Total operating cost
6.07%5.02B
2.19%19.36B
3.36%14.44B
7.54%9.78B
4.38%4.73B
10.73%18.95B
10.16%13.97B
10.17%9.1B
11.18%4.53B
13.03%17.11B
Operating cost
6.22%4.76B
2.17%18.34B
3.39%13.69B
7.68%9.28B
4.22%4.48B
10.96%17.95B
10.30%13.24B
10.28%8.62B
11.66%4.3B
13.12%16.17B
Operating tax surcharges
10.78%11.04M
3.04%43.55M
2.34%30.16M
1.16%19.86M
9.95%9.96M
7.81%42.26M
-3.29%29.47M
0.50%19.63M
4.49%9.06M
6.92%39.2M
Operating expense
8.84%114.82M
2.07%441.71M
5.03%325.35M
7.49%218.38M
6.21%105.49M
14.09%432.77M
9.97%309.78M
9.88%203.18M
10.20%99.33M
10.16%379.34M
Administration expense
3.65%78.01M
3.51%309.28M
1.33%223.74M
4.31%151.49M
7.85%75.26M
-7.17%298.78M
-1.44%220.81M
0.19%145.23M
-9.48%69.79M
14.13%321.87M
Financial expense
-8.91%52.73M
1.30%222.91M
0.77%167.06M
1.58%110.7M
8.13%57.89M
15.01%220.05M
19.33%165.79M
19.42%108.97M
9.51%53.54M
11.92%191.33M
-Interest expense (Financial expense)
-0.47%50.78M
1.71%222.85M
1.08%151M
3.24%101.44M
8.70%51.02M
15.15%219.1M
11.72%149.38M
13.22%98.25M
2.38%46.93M
16.08%190.28M
-Interest Income (Financial expense)
16.62%-1.04M
-33.27%-5.14M
11.67%-3.66M
-48.82%-3.75M
-34.98%-1.25M
25.53%-3.86M
17.04%-4.14M
-0.52%-2.52M
24.77%-924.76K
-49.44%-5.18M
Research and development
58.31%1.22M
33.47%5.53M
-0.77%2.84M
38.41%1.94M
27.61%769.3K
39.51%4.15M
24.78%2.86M
-16.03%1.4M
-6.08%602.86K
-23.01%2.97M
Credit Impairment Loss
-2.20%-12.28M
70.15%-14.71M
13.57%-18.28M
24.51%-10.94M
-17.29%-12.02M
-57.46%-49.3M
-2.77%-21.15M
-25.30%-14.49M
-33.37%-10.25M
-117.61%-31.31M
Asset Impairment Loss
-426.72%-575.39K
17.53%-2.58M
88.66%-579.62K
92.46%-328.6K
95.94%-109.24K
55.64%-3.13M
-30.06%-5.11M
2.58%-4.36M
-5,138.03%-2.69M
73.29%-7.05M
Other net revenue
-26.33%-14.81M
65.76%-17.53M
34.44%-16.25M
58.61%-7.51M
4.32%-11.73M
-67.33%-51.19M
-41.73%-24.79M
-23.70%-18.13M
-76.93%-12.26M
-22.40%-30.59M
Fair value change income
--0
----
----
----
--0
----
----
----
----
----
Invest income
-37.48%-3.55M
-75.66%-12.16M
-95.55%-4.85M
-17.43%-1.66M
-577.61%-2.58M
-224.12%-6.92M
-404.65%-2.48M
45.20%-1.42M
55.54%-381.18K
-6.63%-2.14M
Net open hedge income
--0
----
----
----
--0
----
----
----
----
----
-Including: Investment income associates
--0
-117.01%-154.29K
--1.46M
----
--0
--906.8K
----
----
----
----
Asset deal income
79.01%-3.61K
117.85%275.98K
-193.17%-116.29K
-214.01%-151.56K
-124.56%-17.21K
123.78%126.69K
218.41%124.81K
1,267.52%132.94K
988.39%70.09K
-2,068.87%-532.8K
Other revenue
-46.78%1.6M
45.10%11.65M
97.82%7.58M
179.22%5.58M
202.17%3M
-23.08%8.03M
-39.34%3.83M
-49.75%2M
-36.66%992.37K
-41.29%10.44M
Operating profit
4.21%105.52M
0.56%468.56M
-2.66%322.45M
3.73%232.48M
6.53%101.26M
14.80%465.94M
8.50%331.26M
11.55%224.12M
12.74%95.05M
8.59%405.88M
Add:Non operating Income
44.74%246.55K
-33.82%2.65M
-49.84%1.23M
-39.96%1.17M
-79.99%170.34K
-66.67%4.01M
83.86%2.45M
146.81%1.94M
121.36%851.11K
455.19%12.03M
Less:Non operating expense
7.31%227.06K
-54.66%1.79M
1.25%932.76K
29.82%651.06K
28.10%211.6K
46.46%3.94M
-43.63%921.27K
-59.13%501.52K
-83.76%165.19K
-43.62%2.69M
Total profit
4.27%105.54M
0.73%469.42M
-3.02%322.74M
3.29%233M
5.72%101.22M
12.23%466.01M
9.10%332.79M
12.51%225.57M
14.41%95.74M
11.87%415.22M
Less:Income tax cost
-2.67%22.02M
-8.79%104.93M
-21.21%63.68M
-23.58%42.9M
-7.32%22.62M
4.01%115.04M
6.41%80.83M
10.05%56.14M
7.92%24.41M
6.05%110.6M
Net profit
6.26%83.52M
3.85%364.49M
2.82%259.06M
12.20%190.1M
10.19%78.6M
15.22%350.97M
10.00%251.96M
13.35%169.42M
16.81%71.33M
14.15%304.61M
Net profit from continuing operation
6.26%83.52M
3.85%364.49M
2.82%259.06M
12.20%190.1M
10.19%78.6M
15.22%350.97M
10.00%251.96M
13.35%169.42M
16.81%71.33M
14.15%304.61M
Less:Minority Profit
80.02%-252.02K
-83.43%964.06K
-365.49%-2.92M
64.19%1.08M
-238.00%-1.26M
562.10%5.82M
135.16%1.1M
118.95%659.13K
89.37%-373.13K
-635.16%-1.26M
Net profit of parent company owners
4.90%83.78M
5.32%363.53M
4.43%261.98M
12.00%189.01M
11.37%79.86M
12.84%345.16M
8.04%250.86M
10.34%168.76M
11.04%71.71M
14.72%305.87M
Earning per share
Basic earning per share
4.76%0.22
5.62%0.94
3.08%0.67
13.95%0.49
16.67%0.21
12.66%0.89
8.33%0.65
10.26%0.43
5.88%0.18
6.76%0.79
Other composite income
101.17%5.17K
-69.35%1.02M
-67.86%1.22M
-16.83%1.34M
-58.21%-441.71K
435.34%3.32M
1,234.13%3.78M
528.46%1.61M
-289.85%-279.2K
50.29%-990.09K
Other composite income of parent company owners
101.17%5.17K
-69.35%1.02M
-67.86%1.22M
-16.83%1.34M
-58.21%-441.71K
435.34%3.32M
1,234.13%3.78M
528.46%1.61M
-289.85%-279.2K
50.29%-990.09K
Total composite income
6.87%83.53M
3.17%365.51M
1.77%260.28M
11.93%191.43M
10.00%78.16M
16.69%354.29M
11.81%255.74M
14.71%171.03M
16.07%71.05M
14.63%303.62M
Total composite income of parent company owners
5.49%83.78M
4.61%364.55M
3.36%263.19M
11.73%190.35M
11.19%79.42M
14.30%348.48M
9.83%254.64M
11.67%170.37M
10.36%71.43M
15.21%304.88M
Total composite income of minority owners
80.02%-252.02K
-83.43%964.06K
-365.49%-2.92M
64.19%1.08M
-238.00%-1.26M
562.10%5.82M
135.16%1.1M
118.95%659.13K
89.37%-373.13K
-635.16%-1.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 6.08%5.14B1.97%19.85B3.15%14.78B7.32%10.02B4.40%4.84B10.93%19.46B10.16%14.32B10.22%9.34B11.32%4.64B12.94%17.55B
Operating revenue 6.08%5.14B1.97%19.85B3.15%14.78B7.32%10.02B4.40%4.84B10.93%19.46B10.16%14.32B10.22%9.34B11.32%4.64B12.94%17.55B
Other operating revenue ----7.03%60.56M----3.13%26.54M----52.24%56.58M----89.66%25.73M----3.15%37.16M
Total operating cost 6.07%5.02B2.19%19.36B3.36%14.44B7.54%9.78B4.38%4.73B10.73%18.95B10.16%13.97B10.17%9.1B11.18%4.53B13.03%17.11B
Operating cost 6.22%4.76B2.17%18.34B3.39%13.69B7.68%9.28B4.22%4.48B10.96%17.95B10.30%13.24B10.28%8.62B11.66%4.3B13.12%16.17B
Operating tax surcharges 10.78%11.04M3.04%43.55M2.34%30.16M1.16%19.86M9.95%9.96M7.81%42.26M-3.29%29.47M0.50%19.63M4.49%9.06M6.92%39.2M
Operating expense 8.84%114.82M2.07%441.71M5.03%325.35M7.49%218.38M6.21%105.49M14.09%432.77M9.97%309.78M9.88%203.18M10.20%99.33M10.16%379.34M
Administration expense 3.65%78.01M3.51%309.28M1.33%223.74M4.31%151.49M7.85%75.26M-7.17%298.78M-1.44%220.81M0.19%145.23M-9.48%69.79M14.13%321.87M
Financial expense -8.91%52.73M1.30%222.91M0.77%167.06M1.58%110.7M8.13%57.89M15.01%220.05M19.33%165.79M19.42%108.97M9.51%53.54M11.92%191.33M
-Interest expense (Financial expense) -0.47%50.78M1.71%222.85M1.08%151M3.24%101.44M8.70%51.02M15.15%219.1M11.72%149.38M13.22%98.25M2.38%46.93M16.08%190.28M
-Interest Income (Financial expense) 16.62%-1.04M-33.27%-5.14M11.67%-3.66M-48.82%-3.75M-34.98%-1.25M25.53%-3.86M17.04%-4.14M-0.52%-2.52M24.77%-924.76K-49.44%-5.18M
Research and development 58.31%1.22M33.47%5.53M-0.77%2.84M38.41%1.94M27.61%769.3K39.51%4.15M24.78%2.86M-16.03%1.4M-6.08%602.86K-23.01%2.97M
Credit Impairment Loss -2.20%-12.28M70.15%-14.71M13.57%-18.28M24.51%-10.94M-17.29%-12.02M-57.46%-49.3M-2.77%-21.15M-25.30%-14.49M-33.37%-10.25M-117.61%-31.31M
Asset Impairment Loss -426.72%-575.39K17.53%-2.58M88.66%-579.62K92.46%-328.6K95.94%-109.24K55.64%-3.13M-30.06%-5.11M2.58%-4.36M-5,138.03%-2.69M73.29%-7.05M
Other net revenue -26.33%-14.81M65.76%-17.53M34.44%-16.25M58.61%-7.51M4.32%-11.73M-67.33%-51.19M-41.73%-24.79M-23.70%-18.13M-76.93%-12.26M-22.40%-30.59M
Fair value change income --0--------------0--------------------
Invest income -37.48%-3.55M-75.66%-12.16M-95.55%-4.85M-17.43%-1.66M-577.61%-2.58M-224.12%-6.92M-404.65%-2.48M45.20%-1.42M55.54%-381.18K-6.63%-2.14M
Net open hedge income --0--------------0--------------------
-Including: Investment income associates --0-117.01%-154.29K--1.46M------0--906.8K----------------
Asset deal income 79.01%-3.61K117.85%275.98K-193.17%-116.29K-214.01%-151.56K-124.56%-17.21K123.78%126.69K218.41%124.81K1,267.52%132.94K988.39%70.09K-2,068.87%-532.8K
Other revenue -46.78%1.6M45.10%11.65M97.82%7.58M179.22%5.58M202.17%3M-23.08%8.03M-39.34%3.83M-49.75%2M-36.66%992.37K-41.29%10.44M
Operating profit 4.21%105.52M0.56%468.56M-2.66%322.45M3.73%232.48M6.53%101.26M14.80%465.94M8.50%331.26M11.55%224.12M12.74%95.05M8.59%405.88M
Add:Non operating Income 44.74%246.55K-33.82%2.65M-49.84%1.23M-39.96%1.17M-79.99%170.34K-66.67%4.01M83.86%2.45M146.81%1.94M121.36%851.11K455.19%12.03M
Less:Non operating expense 7.31%227.06K-54.66%1.79M1.25%932.76K29.82%651.06K28.10%211.6K46.46%3.94M-43.63%921.27K-59.13%501.52K-83.76%165.19K-43.62%2.69M
Total profit 4.27%105.54M0.73%469.42M-3.02%322.74M3.29%233M5.72%101.22M12.23%466.01M9.10%332.79M12.51%225.57M14.41%95.74M11.87%415.22M
Less:Income tax cost -2.67%22.02M-8.79%104.93M-21.21%63.68M-23.58%42.9M-7.32%22.62M4.01%115.04M6.41%80.83M10.05%56.14M7.92%24.41M6.05%110.6M
Net profit 6.26%83.52M3.85%364.49M2.82%259.06M12.20%190.1M10.19%78.6M15.22%350.97M10.00%251.96M13.35%169.42M16.81%71.33M14.15%304.61M
Net profit from continuing operation 6.26%83.52M3.85%364.49M2.82%259.06M12.20%190.1M10.19%78.6M15.22%350.97M10.00%251.96M13.35%169.42M16.81%71.33M14.15%304.61M
Less:Minority Profit 80.02%-252.02K-83.43%964.06K-365.49%-2.92M64.19%1.08M-238.00%-1.26M562.10%5.82M135.16%1.1M118.95%659.13K89.37%-373.13K-635.16%-1.26M
Net profit of parent company owners 4.90%83.78M5.32%363.53M4.43%261.98M12.00%189.01M11.37%79.86M12.84%345.16M8.04%250.86M10.34%168.76M11.04%71.71M14.72%305.87M
Earning per share
Basic earning per share 4.76%0.225.62%0.943.08%0.6713.95%0.4916.67%0.2112.66%0.898.33%0.6510.26%0.435.88%0.186.76%0.79
Other composite income 101.17%5.17K-69.35%1.02M-67.86%1.22M-16.83%1.34M-58.21%-441.71K435.34%3.32M1,234.13%3.78M528.46%1.61M-289.85%-279.2K50.29%-990.09K
Other composite income of parent company owners 101.17%5.17K-69.35%1.02M-67.86%1.22M-16.83%1.34M-58.21%-441.71K435.34%3.32M1,234.13%3.78M528.46%1.61M-289.85%-279.2K50.29%-990.09K
Total composite income 6.87%83.53M3.17%365.51M1.77%260.28M11.93%191.43M10.00%78.16M16.69%354.29M11.81%255.74M14.71%171.03M16.07%71.05M14.63%303.62M
Total composite income of parent company owners 5.49%83.78M4.61%364.55M3.36%263.19M11.73%190.35M11.19%79.42M14.30%348.48M9.83%254.64M11.67%170.37M10.36%71.43M15.21%304.88M
Total composite income of minority owners 80.02%-252.02K-83.43%964.06K-365.49%-2.92M64.19%1.08M-238.00%-1.26M562.10%5.82M135.16%1.1M118.95%659.13K89.37%-373.13K-635.16%-1.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg